The study authors stated patients at risk of HDFN must be closely monitored throughout pregnancy to improve outcomes.

If your infant has a blood transfusion, their blood type may temporarily change, but it will eventually return to its original type.

Researchers identified three biomarkers that are raised in patients with HDFN associated with ABO incompatibility.

Routine antenatal anti-D prophylaxis, a key preventative blood product used to reduce risk in hemolytic disease of the fetus ...

Early detection and treatment reduce fetal death and severe anemia, and nipocalimab can help detect HDFN earlier and prevent ...

The study showed cord blood is safe to use in transfusions as long as it is used quickly. Umbilical cord blood (UCB) may be a viable transfusion option for patients with hemolytic disease of the fetus ...

Gel microcolumn assay (GMA) effectively identifies pregnancies at high risk for severe HDFN, but its false positivity rate ...